Related Experiment Video
Updated: Oct 11, 2025

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Variation in glucocorticoid sensitivity and the relation with obesity
Robin Lengton1,2, Anand M Iyer1,3, Eline S van der Valk1,3
1Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
High cortisol levels are linked to obesity. Understanding glucocorticoid (GC) sensitivity is key for developing personalized weight loss therapies targeting the GC receptor.
Area of Science:
- Endocrinology
- Metabolic Research
- Pharmacology
Background:
- Growing evidence links increased glucocorticoid (GC) exposure to weight gain.
- Hair cortisol analysis shows high physiological GC levels in many individuals with obesity.
- Understanding the mechanisms is crucial for targeted obesity therapies.
Purpose of the Study:
- To review mechanisms influencing GC sensitivity in obesity.
- To explore the relationship between GC sensitivity and obesity.
- To discuss personalized treatment strategies targeting the GC receptor.
Main Methods:
- Review of current scientific literature on glucocorticoids and obesity.
- Analysis of factors affecting GC sensitivity (e.g., genetic, acquired).
- Discussion of functional GC assays and GC receptor function.
Main Results:
- GC effects depend on concentration, sensitivity, and target tissue.
- GC sensitivity is influenced by intracellular availability, receptor levels, and gene modulation.
- Individual differences in GC sensitivity impact responses to exogenous GCs.
Conclusions:
- GC sensitivity is a critical factor in obesity development and GC treatment response.
- Personalized medicine approaches targeting the GC receptor show promise for sustainable weight loss.
- Further research into GC sensitivity mechanisms can guide novel therapeutic interventions.
More Related Videos
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
08:02Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
Published on: April 25, 2016
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Hypoglycemia and Glucagon
Obesity
Dosage Regimen: Individualization